PAF1 homolog, Paf1/RNA polymerase II complex component
RGD ID:
1306219
Description:
Predicted to enable RNA polymerase II complex binding activity and chromatin binding activity. Predicted to be involved in several processes, including RNA metabolic process; positive regulation of cell cycle G1/S phase transition; and regulation of transcription by RNA polymerase II. Predicted to be located in cytoplasm; membrane; and nuclear lumen. Predicted to be part of Cdc73/Paf1 complex. Orthologous to human PAF1 (PAF1 homolog, Paf1/RNA polymerase II complex component); PARTICIPATES IN RNA polymerase I transcription pathway; RNA polymerase II transcription elongation pathway; INTERACTS WITH 2,6-dinitrotoluene; allethrin; bisphenol A.
LOC361531; MGC114568; Paf1, RNA polymerase II associated factor, homolog; Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae); RGD1306219; RNA polymerase II-associated factor 1 homolog; similar to PD2 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein